Literature DB >> 24306067

[Reduced acute toxicity for adults with medulloblastoma treated with proton beam craniospinal irradiation].

M Krause1, M Baumann.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24306067     DOI: 10.1007/s00066-013-0492-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.

Authors:  Aaron P Brown; Christian L Barney; David R Grosshans; Mary Frances McAleer; John F de Groot; Vinay K Puduvalli; Susan L Tucker; Cody N Crawford; Meena Khan; Soumen Khatua; Mark R Gilbert; Paul D Brown; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-20       Impact factor: 7.038

2.  Place of proton radiotherapy in future radiotherapy practice.

Authors:  Daniel Zips; Michael Baumann
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

Review 3.  Clinical controversies: proton therapy for pediatric tumors.

Authors:  Thomas E Merchant
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

4.  Pediatric craniospinal axis irradiation with helical tomotherapy: patient outcome and lack of acute pulmonary toxicity.

Authors:  José Peñagarícano; Eduardo Moros; Peter Corry; Robert Saylors; Vaneerat Ratanatharathorn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-19       Impact factor: 7.038

  4 in total
  2 in total

1.  Medulloblastoma in adults : A retrospective single institution analysis.

Authors:  Indrawati Hadi; Olarn Roengvoraphoj; Maximilian Niyazi; Falk Roeder; Ulrich Schüller; Claus Belka; Silke Birgit Nachbichler
Journal:  Strahlenther Onkol       Date:  2017-11-16       Impact factor: 3.621

2.  Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.

Authors:  Sergiu Scobioala; Ross Parfitt; Peter Matulat; Christopher Kittel; Fatemeh Ebrahimi; Heidi Wolters; Antoinette Am Zehnhoff-Dinnesen; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2017-09-08       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.